DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility

Srikant Ambatipudi; Steve Horvath; Flavie Perrier; Cyrille Cuenin; Hector Hernandez-Vargas; Florence Le Calvez-Kelm; Geoffroy Durand; Graham Byrnes; Pietro Ferrari; Liacine Bouaoun; Athena Sklias; Veronique Chajes; Kim Overvad; Gianluca Seven; Laura Baglietto; Francoise Clavel-Chapelon; Rudolf Kaaks; Myrto Barrdahl; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Androniki Naska; Giovanna Masala; Claudia Agnoli; Silvia Polidoro; Rosario Tumino; Salvatore Panico; Martijn Dolle; Petra HM Peeters; N Charlotte Onland-Moret; Torkjel M Sandanger; Therese H Nost; Elisabete Weiderpass; J Ramon Quiros; Antonio Agudo; Miguel Rodriguez-Barranco; Jose Maria Huerta Castano; Aurelio Barricarte; Ander Matheu Fernandez; Ruth C Travis; Paolo Vineis; David C Muller; Elio Riboli; Marc Gunter; Isabelle Romieu; Zdenko Herceg

Journal article

DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility

Srikant Ambatipudi, Steve Horvath, Flavie Perrier, Cyrille Cuenin, Hector Hernandez-Vargas, Florence Le Calvez-Kelm, Geoffroy Durand, Graham Byrnes, Pietro Ferrari, Liacine Bouaoun, Athena Sklias, Veronique Chajes, Kim Overvad, Gianluca Seven, Laura Baglietto, Francoise Clavel-Chapelon, Rudolf Kaaks, Myrto Barrdahl, Heiner Boeing, Antonia Trichopoulou Show all

European Journal of Cancer | ELSEVIER SCI LTD | Published : 2017

DOI: 10.1016/j.ejca.2017.01.014

University of Melbourne Researchers

Laura Baglietto Author Melbourne School of Population and Global Health

Grants

Awarded by Institut National du Cancer (INCa, France)

Awarded by European Commission (EC)

Awarded by EC

Awarded by NIH/NIA

Awarded by Cancer Research UK

Awarded by Medical Research Council

Funding Acknowledgements

This work was supported by grants from the Institut National du Cancer (INCa, France) (2012-070) to IR and ZH and the European Commission (EC) Seventh Framework Programme (FP7 Exposomics) (308610-2) Translational Cancer Research (TRANSCAN) (TRANS201301184) Framework and the Fondation Association pour la Recherche contre le Cancer (ARC, France) to ZH. ZH was also supported by the EC FP7 EurocanPlatform: A European Platform for Translational Cancer Research (grant number: 260791). Funding for the work also comes from a grant from: "Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy" and the Regional Government of Asturias. EPIC Greece is supported by the Hellenic Health Foundation. SH was supported by NIH/NIA 1U34AG051425-01. The funders of the study had no role in study design, data collection, data analysis, data interpretation or writing of the manuscript.